NCT02381236View on ClinicalTrials.gov

G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

February 28, 2017

Conditions

Prostatic Neoplasms

Interventions

DRUG

G-202

G-202 administered by intravenous infusion on Days 1, 2 and 3 of each 28-day cycle for up to 3 cycles

Trial Locations (1)

77030

University of Texas Health Sciences Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

GenSpera, Inc.

INDUSTRY